Codelivery of Raloxifene and Rutin as PEGylated Nanoliposomes: Formulation, Characterization, and Prophylactic Activity Against Breast Cancer
PEGylated NLs loaded with RLX and rutin demonstrated safe anti-breast cancer effects, outperforming mixed NLs, suggesting the potential for a safer and more targeted treatment. Further investigations are needed into clinical translation.
Authors
- Ali Mahmoud Al-Samydai (ORCID: https://orcid.org/0000-0003-0093-2310)
- Khaldun M. Al Azzam (ORCID: https://orcid.org/0000-0003-4097-6991)
- Walhan Alshaer (ORCID: https://orcid.org/0000-0003-2946-7328)
- Aya Y. Al‐Kabariti (ORCID: https://orcid.org/0000-0002-5189-576X)
- Simone Carradori (ORCID: https://orcid.org/0000-0002-8698-9440)
- Maryam Abdulmaged Oleiwi
Institutions
- Al-Ahliyya Amman University (JO)
- University of Jordan (JO)
- University of Chieti-Pescara (IT)
Publication Details
- Journal
- Advanced Pharmaceutical Bulletin
- Published
- 2025-06-28
- DOI
- https://doi.org/10.34172/apb.025.43681
- Citations
- 2
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.19
Funders
- University of Jordan
- Al-Ahliyya Amman University